Related Experiment Video
Updated: Aug 11, 2026

Determination of the Relative Potency of an Anti-TNF Monoclonal Antibody (mAb) by Neutralizing TNF Using an In Vitro Bioanalytical Method
Published on: September 16, 2017
Characterization of serum adhesive proteins that block tumor necrosis factor-mediated cell death
N S Chang1, N Joki, J Mattison
1Research Institute, Laboratory of Molecular Immunology, Guthrie Medical Center, Sayre, Pennsylvania 18840, USA. nschang@inet.guthrie.org
Abstract:
Previously we have shown that TGF-beta1 protects murine L929 fibroblasts from TNF/ActD-mediated cell death by inducing the expression of an extracellular matrix TNF-resistance triggering (TRT) protein. TRT promotes TNF-resistance via activation of tyrosine and serine/threonine kinases in L929 cells. To examine the presence of TRT activity in serum (designated STRT), human sera were diluted, treated with or without PMSF and subjected to sequential ammonium sulfate precipitation (ASP). Aliquots of the ASP protein fractions were coated onto 96-well plates, followed by thorough washing. When L929 cells were seeded and cultured on the wells coated with STRT proteins, these cells resisted killing by TNF, TNF/ActD, doxorubicin and serum deprivation, but not by anti-Fas/ActD, staurosporine and ActD. STRT activity was found at the 15% ASP fraction of untreated sera, but shifted to the 20% ASP fraction of PMSF-treated sera. Two likely STRT proteins of approximately 226 and 265 kDa were found in these fractions, compared to the corresponding nonfunctional ASP fractions. Functionally, STRT was inactivated by trypsin, but not by 5 M salt, various serine and/or cysteine protease inhibitors, and antibodies against fibronectin, vitronectin, C1q, histidine-rich glycoprotein, CD44, chondroitin sulfate and hyaluronic acid. STRT failed to alter the expression of proteins involved in apoptosis such as RIP, ICH-1L, BCL-X, TIAR and IkappaBalpha, and could not induce IkappaBalpha degradation. The induced TNF-resistance could be reversed by treatment of STRT-stimulated cells with testicular hyaluronidase, as well as with tyrosine kinase inhibitors tyrophostin, lavendustin A and AG-490 (a selective inhibitor of JAK2 kinase). However, the STRT function could not be blocked by the MEK kinase inhibitor PD98059 and the NF-kappaB inhibitors curcumin and a synthetic inhibitor peptide for NF-kappaB translocation. Together, our data suggest that tyrosine kinase activation is involved in the STRT-mediated resistance to TNF and TNF/ActD in L929 cells.
Insights
Serum-derived TNF-resistance triggering (STRT) proteins protect L929 fibroblasts from cell death. STRT activity involves tyrosine kinase activation, conferring resistance to TNF and doxorubicin but not Fas-mediated apoptosis.
Area of Science:
- Cell Biology
- Biochemistry
- Immunology
Background:
- Transforming growth factor-beta1 (TGF-beta1) induces an extracellular matrix TNF-resistance triggering (TRT) protein in L929 fibroblasts.
- TRT confers resistance to TNF/ActD-mediated cell death through tyrosine and serine/threonine kinase activation.
Purpose of the Study:
- To investigate the presence and function of TRT-like activity in human serum, termed serum TRT (STRT).
- To characterize the biochemical properties and signaling pathways involved in STRT-mediated cell protection.
Main Methods:
- Human sera were fractionated using sequential ammonium sulfate precipitation (ASP) with or without phenylmethylsulfonyl fluoride (PMSF).
- L929 fibroblasts were cultured on plates coated with STRT protein fractions and challenged with various cell death inducers.
- Proteins were identified, and functional assays were performed using enzyme treatments and specific kinase inhibitors.
Main Results:
- STRT activity was identified in specific ASP fractions of human serum, with a shift observed upon PMSF treatment.
- STRT-coated cells exhibited resistance to TNF, TNF/ActD, doxorubicin, and serum deprivation, but not to anti-Fas/ActD, staurosporine, or ActD alone.
- STRT function was sensitive to trypsin and testicular hyaluronidase but resistant to protease inhibitors and antibodies against various matrix proteins; it involved tyrosine kinase activation, specifically JAK2, and was independent of NF-kappaB signaling.
Conclusions:
- Human serum contains STRT proteins that confer resistance to multiple apoptotic stimuli in L929 fibroblasts.
- STRT-mediated protection involves the activation of tyrosine kinases, particularly JAK2, and is distinct from previously characterized TRT activity.
- These findings suggest a novel mechanism of serum-mediated cell protection involving extracellular matrix interactions and intracellular kinase signaling.
More Related Videos
13:19Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery
Published on: April 26, 2024
07:44Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports
Published on: November 28, 2019
Related Concept Videos
Tumor Immunotherapy
Intracellular Signaling Affects Focal Adhesions
Some...
The Extrinsic Apoptotic Pathway
Cell Adhesion Molecules - Types and Functions
CAM Families
The Integrin family of proteins is primarily involved in a...